Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-437
Closed -$11K 1278
2022
Q1
$11K Buy
+437
New +$10.1K ﹤0.01% 810
2021
Q4
Sell
-437
Closed -$10K 485
2021
Q3
$10K Hold
437
﹤0.01% 695
2021
Q2
$11K Hold
437
﹤0.01% 673
2021
Q1
$9K Hold
437
﹤0.01% 736
2020
Q4
$7K Buy
437
+82
+23% +$911 ﹤0.01% 761
2020
Q3
$3K Sell
355
-445
-56% -$4.29K ﹤0.01% 763
2020
Q2
$8K Sell
800
-15
-2% -$137 ﹤0.01% 694
2020
Q1
$5K Buy
+815
New +$16.9K ﹤0.01% 716
2019
Q3
$31K Hold
1,150
﹤0.01% 599
2019
Q2
$39K Hold
1,150
﹤0.01% 467
2019
Q1
$47K Hold
1,150
﹤0.01% 430
2018
Q4
$31K Sell
1,150
-275
-19% -$10.1K ﹤0.01% 472
2018
Q3
$62K Buy
1,425
+175
+14% +$7.34K ﹤0.01% 408
2018
Q2
$52K Buy
+1,250
New +$51.1K ﹤0.01% 419

Other funds holding CHX

Bartlett & Co's CHX Position: Q2 2022 in Review

Bartlett & Co sold out of ChampionX (CHX) in Q2 2022, closing a stake of 437 shares — an estimated $11K sold.

Bartlett & Co first reported a position in CHX in Q2 2018 and held it in 14 quarters. The position peaked at $62K in Q3 2018. 326 funds tracked by Wall St. Rank hold CHX as of Q2 2022.

  • Bartlett & Co reported no remaining ChampionX position as of Q2 2022 after selling out during the quarter.
  • Bartlett & Co sold 437 ChampionX shares in Q2 2022, an estimated $11K.
  • Bartlett & Co first reported a position in ChampionX in Q2 2018 and held it in 14 quarters.
  • Bartlett & Co's ChampionX position peaked at $62K in Q3 2018.
  • 326 funds tracked by Wall St. Rank held ChampionX as of Q2 2022.

Based on Bartlett & Co's 13F filing for Q2 2022, filed 2 Aug 2022.